HONG KONG and DALIAN, China, April 27, 2026 /PRNewswire/ — At 7:00 a.m. in Dalian, Ms. Zhou opened the “Dalian Intelligent Elderly Care Service Platform“ mini program in her home at Dahua Jinxiuhuacheng. She was booking an assisted bathing service for her semi-disabled father. Just after 10:00 a.m., a professional bathing assistant arrived on time with the necessary equipment. Over the next two hours, the weekly bathing ritual was carried out smoothly through a standardized service process.

This seemingly simple moment is no exception. In fact, it reflects a daily routine that has been replicated across the country by the “City-level Intelligent Elderly Care Service Platform”.

From Family Hardship to Platform Breakthrough: The Answer to a Challenge of Hundreds of Millions

As of the end of 2025, China’s population aged 60 and above reached 320 million, of which more than 40 million were disabled or semi-disabled elderly individuals. “When one family member becomes disabled, the whole family is thrown off balance.” This saying has become a reality for millions of households. The pressing demand for home-based elderly care is transforming from an individual family’s struggle into a societal challenge that must be addressed.

In response, the Ministry of Civil Affairs of PRC has explicitly called for accelerating the development of a three-tiered facility network for elderly care services that connect counties, townships, and villages, while promoting the integration and coordination of home-based, community-based, and institutional elderly care. On April 9, 2026, the Liaoning Provincial Civil Affairs Department further laid out its strategic direction: upgrading quality in urban areas, expanding coverage in rural areas, coordinating urban and rural development, and ensuring targeted support for those most in need. But turning these blueprints into reality requires a key player: who will connect the scattered community meal service points, local service providers, and community health clinics into a cohesive service network?

The solution is none other than a City-level Intelligent Elderly Care Service Platform, which integrates all resources within a 15-minute service circle. Elderly residents or their family members can simply open a mini-program or call a hotline to access one-click requests for the “Six Supports” services: meal assistance, housekeeping assistance, bathing assistance, medical assistance, emergency assistance, and mobility assistance.

The platform’s value extends far beyond on-demand service calls. It acts as a bridge connecting the government, service providers, and families. For the government, it serves as an “accelerator” for policy implementation, enabling full oversight via a single dashboard. For service providers, it functions as a new customer acquisition channel and a quality benchmark. For families, it brings greater choice and peace of mind, making it as easy to find elderly care services as ordering takeout.

Driving this innovation is Neutech Group, which launched its strategic transformation in 2024 to fully enter the elderly care technology and medical-care integration sector. The City-level Intelligent Elderly Care Service Platform developed by the group is positioned as “new infrastructure” for city elderly care service, establishing a digital foundation that connects four levels “government, institutions, communities, and families.”

From Dalian to the Whole Country: Elderly Care “New Infrastructure” in 20 Cities

To date, the City-level Intelligent Elderly Care Service Platform has been launched in Shenyang, Dalian and Nanning, and has expanded to more than 20 cities nationwide, basically forming a nationwide layout. The launched— “Shenyang “Shengqing Wellness (盛情康養)” and “Dalian Intelligent Wellness” platforms cover 30 core elderly care scenarios, serving over 70,000 users, gathering more than 1,950 quality service providers, and offering nearly 10,000 elderly-friendly products and services online.

These figures indicate that when Ms. Zhou in Dalian places an order for assisted bathing services on the platform, it is supported by a fully standardized system encompassing service provider access, automated dispatching, process traceability, and evaluation feedback. This serves as compelling evidence that the “Technology + Healthcare and Elderly Care” dual-engine strategy of Neutech is transitioning from blueprint to reality.

The platform’s ability to scale rapidly nationwide is underpinned by a clear operational pathway. Neutech adopts an integrated online-offline approach: online efforts focus on enhancing platform transaction and operational capabilities, continuously optimizing dispatch algorithms, service evaluation systems, and government supervision dashboards, thereby making the system behind “one-click ordering” increasingly intelligent and efficient; offline, the company establishes talent training bases and senior education centers to continuously supply professional personnel for elderly care services, while also fostering social engagement among the senior population through educational initiatives.

Building on this foundation, Neutech integrates ecosystem partners by incorporating service providers, medical institutions, and community facilities into a unified system, thereby creating a standardized and replicable operating model. Since 2025, the company has successively established joint ventures in Shenyang, Dalian, Shanghai, Fuzhou, and Nanning. Leveraging the resource advantages of Neutech and local state-owned enterprises, it advances localized operations of elderly care technology services and rapidly replicates the standardized system of a “City-level Intelligent Elderly Care Service Platform.”

This model has formed an operational structure described as “One Platform, Two Centers.” Driven by the dual engines of localized joint ventures and standardized output, Neutech is upgrading city-level platforms into a new type of elderly care infrastructure that can be promoted nationwide, with the goal of becoming a trusted digital elderly care partner for governments.

The Future is Here: Turning the Blueprint into Everyday Reality

A city-level platform is not an isolated software system, behind it lies a physical network that integrates education, healthcare, and wellness. This is inextricably linked to Neutech’s multi-business deep synergy strategy of “education enhances healthcare and wellness, healthcare transitions into wellness and supplements education, and wellness supports and complements both healthcare and education.”

On the elderly care services front: Neucare Phoenix Academy has built a nationwide elderly education network comprising “3 branch schools and 8 branch institutes,” with offline paid enrollments exceeding 2,000 in 2025. Wecare Family Nursing Home was awarded the title of “Liaoning Province Five-Star Elderly Care Institution (遼寧省五級養老機構)” (the highest level), achieving an occupancy rate of 93%, of which 96% are seniors aged 80 and above. Wecare Family Nursing Home has fully deployed the “Ruixintong (睿新通)” integrated medical, wellness, and elderly care SAAS service system, serving as a demonstration and validation center for Intelligent elderly care solutions.

On the medical services front: Ruikang Cardiovascular Hospital undertook the national cardiovascular high-risk screening project, becoming the solely designated screening institution in the Liaoning region, with nearly 58,000 outpatient and emergency visits in 2025. Ruikang Stomatology Hospital was awarded the honor of Liaoning Province Elderly-Friendly Medical Institution (《遼寧省老年友善醫療機構》), with annual outpatient visits exceeding 23,000. These medical resources and elderly care services have formed a positive collaborative mechanism of “healthcare transitions into wellness and supplements education,” providing the city-level platform with solid service supply capabilities.

The “15-minute elderly care service circle,” established by the Ministry of Civil Affairs, is a service network centered on the provision of the “six assistance services.” While a City-level Intelligent Elderly Care Service Platform is just like an engine that drives the efficient operation of these services within the 15-minute service radius.

Powered by “AI + big data,” the platform integrates scenarios such as bed searching, service matching, policy inquiries, and subsidy applications into a unified system. By bridging information gaps between supply and demand, it transforms fragmented services into a seamlessly connected network. Home-based care, community care, and institutional care are coordinated through unified resource allocation and service integration, aligning with the Ministry’s vision of “integrated and coordinated” service delivery.

Returning to Ms. Zhou’s daily life, she reflects that “home-based elderly care” once felt like a heavy burden. Today, however, it is becoming increasingly manageable—not because her family has suddenly gained more capacity, but because a reliable network of elderly care is gradually taking shape.

From Dalian to Shenyang, from Nanning to Shanghai, Neutech Group is deploying a combination of city-level Intelligent elderly care platforms, localized joint ventures, and integrated healthcare service networks. This coordinated approach is expanding the coverage of the care network from an individual city to a nationwide scale, turning the vision into everyday services that are used by tens of thousands of users in cities across China.

By connecting resources through platforms, empowering ecosystems through technology, and driving services with data, the challenges of elderly care will gradually be alleviated—replaced by a society-wide system of reassurance and support.

Contact
Wei Lin
weilin@neuedu.com
+852 37953236

HONG KONG, April 28, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) today announced that ivonescimab, the company’s first-in-class PD-1/VEGF bispecific antibody, has secured multiple authoritative updates and upgrades across first-line and later-line settings in the officially updated 2026 Chinese Society of Clinical Oncology (CSCO) Guideline for the Diagnosis and Treatment of Non-Small Cell Lung Cancer (NSCLC). These strong recommendations further solidify ivonescimab’s breakthrough clinical value and its position as a new standard of care (SOC), highlighting its leadership as a next-generation immunotherapy driving the IO 2.0 era.

Key Highlights

In the Phase III HARMONi-2 study, ivonescimab monotherapy demonstrated superior progression-free survival compared with pembrolizumab in first-line PD-L1-positive (TPS ≥1%) NSCLC. Based on these results, ivonescimab has been upgraded to a Class I recommendation for first-line treatment of both squamous and non-squamous NSCLC with PD-L1 TPS ≥1%. This indication was previously approved in China and included in the National Reimbursement Drug List (NRDL). The upgrade strengthens its position as a preferred first-line option for PD-L1-positive advanced NSCLC.

In the Phase III HARMONi-6 study, ivonescimab plus chemotherapy showed positive results versus PD-1 inhibitor plus chemotherapy in first-line squamous NSCLC. This combination has received a new Class II recommendation for first-line treatment of squamous NSCLC. The supplemental application for this indication is currently under regulatory review.

Latest CSCO Guideline Recommendations for Ivonescimab

• Post-resistance treatment in EGFR-mutant NSCLC: Ivonescimab plus chemotherapy maintains a Class I recommendation.
• First-line treatment for advanced driver gene-negative squamous NSCLC with PD-L1 TPS ≥1%: Ivonescimab monotherapy upgraded to Class I recommendation.
• First-line treatment for advanced driver gene-negative non-squamous NSCLC with PD-L1 TPS ≥1%: Ivonescimab monotherapy upgraded to Class I recommendation.
• First-line treatment for advanced driver gene-negative squamous NSCLC: Ivonescimab plus chemotherapy newly added as Class II recommendation.

To date, the breakthrough clinical value of ivonescimab has been demonstrated in dozens of clinical trials and real-world experience involving more than 70,000 patients. It has gained wide acceptance among oncologists and patients, contributing to the ongoing advancement of immuno-oncology treatment paradigms globally.

About Akeso

Akeso (HKEX: 9926.HK) is a leading biopharmaceutical company committed to the research, development, manufacturing and commercialization of the world’s first or best-in-class innovative biological medicines. Founded in 2012, the company has established a robust R&D innovation ecosystem centered on its Tetrabody antibody technology platform, AI-powered drug R&D platform, Dual-Shield ADC technology platform, Dual-Lock T-cell engager (TCE) technology platform, Tissue-Smart siRNA/mRNA technology platform, and cell therapy technology platforms. Supported by a global-standard GMP manufacturing infrastructure and a highly efficient, integrated commercialization model, the company has evolved into a globally competitive biopharmaceutical focused on innovative solutions. With fully integrated multi-functional platform, Akeso is internally working on a robust pipeline of over 50 innovative assets in the fields of cancer, autoimmune disease, inflammation, metabolic disease and other major diseases. Among them, 27 candidates have entered clinical trials (including 15 bispecific/multispecific antibodies and bispecific ADCs. Additionally, 7 new drugs are commercially available. Through efficient and breakthrough R&D innovation, Akeso always integrates superior global resources, develops the first-in-class and best-in-class new drugs, provides affordable therapeutic antibodies for patients worldwide, and continuously creates more commercial and social values to become a global leading biopharmaceutical enterprise.

Forward-Looking Statements

This announcement by Akeso, Inc. (9926.HK, “Akeso”) contains “forward-looking statements”. These statements reflect the current beliefs and expectations of Akeso’s management and are subject to significant risks and uncertainties. These statements are not intended to form the basis of any investment decision or any decision to purchase securities of Akeso. There can be no assurance that the drug candidate(s) indicated in this announcement or Akeso’s other pipeline candidates will obtain the required regulatory approvals or achieve commercial success. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in P.R.China, the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Akeso’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the Akeso’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

Akeso does not undertake any obligation to publicly revise these forward-looking statements to reflect events or circumstances after the date hereof, except as required by law.

The recognition highlights Grundfos Pumps India’s market leadership in sustainable pumps, industrial water management, and energy-efficient pumping solutions driven by digitalization and water stewardship.

SAN ANTONIO, April 28, 2026 /PRNewswire/ — Frost & Sullivan is pleased to announce that Grundfos Pumps India Pvt. Ltd. has received the 2026 Indian Company of the Year Recognition in the Sustainable Pumps for Industrial Water category for its outstanding achievements in sustainability-led innovation, strategy execution, and measurable customer impact. This recognition underscores the company’s consistent leadership in advancing energy-efficient pumping systems, strengthening its position in India’s industrial water market, and enabling customers to manage water and energy more responsibly in an increasingly resource-constrained environment.

Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. Grundfos Pumps India excelled in both dimensions, demonstrating a clear ability to align long-term strategic priorities with evolving industrial demand while executing them with discipline, scalability, and consistency. Emphasizing the perspective shared in the assessment, Fredrick Royan, Associate Partner, Sustainability at Frost & Sullivan, said, “Grundfos Pumps India is positioned to shape the next phase of industrial water pumps by combining technological ambition with verifiable sustainability outcomes, transforming water management into a strategic driver of national progress and competitive differentiation.”

Guided by a long-term growth strategy centered on sustainability, digitalization, and application-centric engagement, Grundfos Pumps India has demonstrated strategic agility in adapting global engineering expertise to local industrial realities. The company’s sustained investment in smart pumping technologies, variable-speed solutions, and data-enabled system optimization has allowed it to scale effectively across high-growth industrial sectors in India, including manufacturing, food and beverage, pharmaceuticals, mobility, semiconductors, and energy-intensive process industries.

Innovation remains integral to Grundfos Pumps India’s approach to the industrial water ecosystem. Its comprehensive portfolio of sustainable pumps, pump systems, digital controls, and smart filtration solutions addresses the full lifecycle of industrial water management, from intake and treatment to reuse and discharge. By enabling demand-based pumping, advanced monitoring, and adaptive control, these solutions help customers reduce energy consumption, lower operational costs, and improve system reliability.

“India’s industrial transformation will be defined by how intelligently we manage water. At Grundfos, we see technology not just as an enabler, but as a catalyst for a more resilient and resource‑positive future. By combining advanced pumping intelligence with data‑driven water management, we are empowering industries to move beyond incremental efficiency and embrace system‑level sustainability that safeguards both operational continuity and long‑term competitiveness,” said Shankar Rajaram, Head of Sales, IND Division at Grundfos Pumps India.

Grundfos Pumps India’s emphasis on customer experience reinforces its leadership in sustainable pumps for industrial water. The company supports customers through digital services, optimization programs, repair and lifecycle services, and transparent engagement models that allow users to validate performance before and after deployment. Its application-driven methodology, combined with localized sales and service support across India, enables long-term partnerships built on trust, reliability, and measurable outcomes rather than stand-alone product transactions.

Frost & Sullivan commends Grundfos Pumps India for setting a high benchmark in competitive strategy, execution excellence, and market responsiveness. The company’s ability to integrate smart pumping, digital platforms, renewable energy alignment, and water stewardship is shaping the future of industrial water management in India and delivering tangible economic and environmental value at scale.

Each year, Frost & Sullivan presents the Company of the Year Recognition to an organization that demonstrates outstanding strategy development and implementation, resulting in measurable improvements in market performance, customer value, and competitive positioning. The recognition highlights organizations that are redefining industry standards through innovation, excellence in growth, and long-term impact.

Frost & Sullivan Best Practices Recognition
Frost & Sullivan’s Best Practices Recognition honors companies across regional and global markets that exhibit exceptional achievement and consistent excellence in areas such as leadership, technological innovation, customer experience, and strategic product development. Each recognition is the result of a rigorous analytical process in which Frost & Sullivan industry experts benchmark performance through comprehensive interviews, deep-dive analysis, and extensive secondary research. The goal is to identify true best-in-class organizations that are driving transformative growth and setting new industry standards.
Contact us: Start the discussion.

Contact:
Tarini Singh
E: Tarini.Singh@frost.com

About Grundfos
Grundfos Pumps India Pvt. Ltd. (Grundfos India) is a 100% subsidiary of Grundfos – Denmark. A global leader in advanced pump solutions and a trendsetter in water technology, the company manufactures more than 16 million pump units annually. The company’s main products include circulator pumps for heating and air-conditioning, as well as other centrifugal pumps for the industry, water supply, sewage, and dosing. The company contributes to global sustainability by pioneering technologies that improve the quality of life for people and care for the planet.

Find out more: http://www.grundfos.com/in

For more information
Please contact: 
Giridhar Raisom | Grundfos
Email: giridhar@grundfos.com
Mobile: +919150071496